vs
Applied Therapeutics, Inc.(APLT)与Palladyne AI Corp.(PDYN)财务数据对比。点击上方公司名可切换其他公司
Palladyne AI Corp.的季度营收约是Applied Therapeutics, Inc.的1.7倍($1.7M vs $1.0M),Palladyne AI Corp.净利率更高(-89.9% vs -1899.0%,领先1809.1%),Applied Therapeutics, Inc.同比增速更快(719.7% vs 118.3%)
Relief Therapeutics是一家总部位于日内瓦的瑞士生物制药企业,专注于为现有治疗方案稀缺或空白的重症领域研发创新药物。其核心在研药物RLF-100是一种可保护肺部的天然肽合成制剂,公司于2016年在瑞士证券交易所挂牌上市。
Palladyne AI Corp是一家美国企业,其前身1983年成立时名为萨科斯研究公司,企业长期以来以机器人开发为核心业务。2023年,公司调整业务方向,专注开发适用于机器人场景的人工智能软件,终止了硬件业务,并于2024年3月正式更名为现用名。
APLT vs PDYN — 直观对比
营收规模更大
PDYN
是对方的1.7倍
$1.0M
营收增速更快
APLT
高出601.4%
118.3%
净利率更高
PDYN
高出1809.1%
-1899.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.0M | $1.7M |
| 净利润 | $-19.0M | $-1.5M |
| 毛利率 | — | 15.6% |
| 营业利润率 | -1675.8% | -560.7% |
| 净利率 | -1899.0% | -89.9% |
| 营收同比 | 719.7% | 118.3% |
| 净利润同比 | 72.3% | 97.2% |
| 每股收益(稀释后) | $-0.13 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APLT
PDYN
| Q4 25 | — | $1.7M | ||
| Q3 25 | $1.0M | $860.0K | ||
| Q2 25 | $0 | $1.0M | ||
| Q1 25 | $0 | $1.7M | ||
| Q4 24 | $-1.0K | $761.0K | ||
| Q3 24 | — | $871.0K | ||
| Q2 24 | $144.0K | $2.7M | ||
| Q1 24 | $190.0K | $3.4M |
净利润
APLT
PDYN
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $-19.0M | $-3.7M | ||
| Q2 25 | $-21.3M | $-7.5M | ||
| Q1 25 | $-21.8M | $22.8M | ||
| Q4 24 | $44.0M | — | ||
| Q3 24 | — | $-7.1M | ||
| Q2 24 | $2.9M | $-5.3M | ||
| Q1 24 | $-83.9M | $-7.2M |
毛利率
APLT
PDYN
| Q4 25 | — | 15.6% | ||
| Q3 25 | — | 46.4% | ||
| Q2 25 | — | 53.3% | ||
| Q1 25 | — | 79.4% | ||
| Q4 24 | — | 27.2% | ||
| Q3 24 | — | 45.0% | ||
| Q2 24 | — | 79.0% | ||
| Q1 24 | — | 45.2% |
营业利润率
APLT
PDYN
| Q4 25 | — | -560.7% | ||
| Q3 25 | -1675.8% | -937.8% | ||
| Q2 25 | — | -797.4% | ||
| Q1 25 | — | -405.3% | ||
| Q4 24 | 3302300.0% | — | ||
| Q3 24 | — | -838.0% | ||
| Q2 24 | -14194.4% | -213.3% | ||
| Q1 24 | -11101.6% | -213.7% |
净利率
APLT
PDYN
| Q4 25 | — | -89.9% | ||
| Q3 25 | -1899.0% | -434.9% | ||
| Q2 25 | — | -737.6% | ||
| Q1 25 | — | 1330.9% | ||
| Q4 24 | -4400700.0% | — | ||
| Q3 24 | — | -814.7% | ||
| Q2 24 | 2012.5% | -196.2% | ||
| Q1 24 | -44177.9% | -210.1% |
每股收益(稀释后)
APLT
PDYN
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $-0.13 | $-0.09 | ||
| Q2 25 | $-0.15 | $-0.20 | ||
| Q1 25 | $-0.15 | $0.55 | ||
| Q4 24 | $0.52 | — | ||
| Q3 24 | — | $-0.27 | ||
| Q2 24 | $-0.13 | $-0.20 | ||
| Q1 24 | $-0.67 | $-0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $11.9M | $47.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-561.0K | $74.7M |
| 总资产 | $34.4M | $95.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
APLT
PDYN
| Q4 25 | — | $47.1M | ||
| Q3 25 | $11.9M | $57.1M | ||
| Q2 25 | $30.4M | $62.7M | ||
| Q1 25 | $50.8M | $46.6M | ||
| Q4 24 | $79.4M | $40.1M | ||
| Q3 24 | — | $21.3M | ||
| Q2 24 | $122.2M | $25.8M | ||
| Q1 24 | $146.5M | $31.8M |
股东权益
APLT
PDYN
| Q4 25 | — | $74.7M | ||
| Q3 25 | $-561.0K | $51.8M | ||
| Q2 25 | $17.4M | $53.8M | ||
| Q1 25 | $36.7M | $28.3M | ||
| Q4 24 | $57.0M | $-9.5M | ||
| Q3 24 | — | $23.4M | ||
| Q2 24 | $72.4M | $29.8M | ||
| Q1 24 | $67.3M | $34.2M |
总资产
APLT
PDYN
| Q4 25 | — | $95.7M | ||
| Q3 25 | $34.4M | $72.9M | ||
| Q2 25 | $37.3M | $78.3M | ||
| Q1 25 | $56.9M | $63.3M | ||
| Q4 24 | $86.7M | $56.3M | ||
| Q3 24 | — | $38.7M | ||
| Q2 24 | $127.8M | $45.1M | ||
| Q1 24 | $151.2M | $50.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-18.4M | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-8.7M |
| 自由现金流率自由现金流/营收 | — | -526.2% |
| 资本支出强度资本支出/营收 | — | 14.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
APLT
PDYN
| Q4 25 | — | $-8.5M | ||
| Q3 25 | $-18.4M | $-6.3M | ||
| Q2 25 | $-20.3M | $-5.3M | ||
| Q1 25 | $-28.6M | $-7.5M | ||
| Q4 24 | $-19.5M | $-22.6M | ||
| Q3 24 | — | $-4.5M | ||
| Q2 24 | $-22.6M | $-5.8M | ||
| Q1 24 | $-18.9M | $-7.2M |
自由现金流
APLT
PDYN
| Q4 25 | — | $-8.7M | ||
| Q3 25 | — | $-6.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | $-22.9M | ||
| Q3 24 | — | $-4.5M | ||
| Q2 24 | — | $-5.9M | ||
| Q1 24 | — | $-7.3M |
自由现金流率
APLT
PDYN
| Q4 25 | — | -526.2% | ||
| Q3 25 | — | -776.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -445.0% | ||
| Q4 24 | — | -3008.1% | ||
| Q3 24 | — | -517.8% | ||
| Q2 24 | — | -218.9% | ||
| Q1 24 | — | -212.1% |
资本支出强度
APLT
PDYN
| Q4 25 | — | 14.2% | ||
| Q3 25 | — | 44.7% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 5.4% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 5.3% | ||
| Q1 24 | — | 1.8% |
现金转化率
APLT
PDYN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.33× | ||
| Q4 24 | -0.44× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -7.80× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图